Indaptus Therapeutics, Inc. (INDP)

Price & Market Data

Price: $1.24

Daily Change: +$0.18 / 14.52%

Daily Range: $0.92 - $1.41

Market Cap: $138,155,632

Daily Volume: 200,297

Performance Metrics

1 Week: -45.86%

1 Month: -72.47%

3 Months: -48.08%

6 Months: -47.80%

1 Year: -91.14%

YTD: -67.51%

About Indaptus Therapeutics, Inc. (INDP)

Comprehensive review of Indaptus Therapeutics, Inc. (INDP). Trading at 1.24, the stock has seen a daily change of +$0.18 / 14.52%. Its market capitalization is 138,155,632. All performance data is available for analysis.

Company Details

Employees: 5

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.

Selected stocks

Prelude Therapeutics Incorporated (PRLD)

Borr Drilling Limited (BORR)

iHeartMedia, Inc. (IHRT)

Helport AI Limited (HPAI)

Galiano Gold Inc. (GAU)